

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of skeletal muscle contraction (GO:0014819) | 9.17243150 |
| 2 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 9.11239828 |
| 3 | plasma membrane repair (GO:0001778) | 7.97847267 |
| 4 | actin filament-based movement (GO:0030048) | 7.62641449 |
| 5 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.34214858 |
| 6 | skeletal muscle fiber development (GO:0048741) | 6.68452458 |
| 7 | striated muscle contraction (GO:0006941) | 6.28732730 |
| 8 | myotube cell development (GO:0014904) | 6.14317497 |
| 9 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.01170192 |
| 10 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.87779920 |
| 11 | regulation of relaxation of muscle (GO:1901077) | 5.57156214 |
| 12 | sarcomere organization (GO:0045214) | 5.55650733 |
| 13 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.47303741 |
| 14 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.31506941 |
| 15 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.13360790 |
| 16 | regulation of cell communication by electrical coupling (GO:0010649) | 5.11321493 |
| 17 | myofibril assembly (GO:0030239) | 4.99251213 |
| 18 | skeletal muscle adaptation (GO:0043501) | 4.94655005 |
| 19 | muscle contraction (GO:0006936) | 4.88036910 |
| 20 | muscle cell cellular homeostasis (GO:0046716) | 4.86089379 |
| 21 | presynaptic membrane assembly (GO:0097105) | 4.65759268 |
| 22 | nucleobase catabolic process (GO:0046113) | 4.65058477 |
| 23 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.48625393 |
| 24 | postsynaptic membrane organization (GO:0001941) | 4.45805846 |
| 25 | presynaptic membrane organization (GO:0097090) | 4.44489435 |
| 26 | response to inactivity (GO:0014854) | 4.42826441 |
| 27 | neuron cell-cell adhesion (GO:0007158) | 4.42781004 |
| 28 | axonal fasciculation (GO:0007413) | 4.37843417 |
| 29 | sequestering of actin monomers (GO:0042989) | 4.35606706 |
| 30 | muscle fiber development (GO:0048747) | 4.33128686 |
| 31 | muscle system process (GO:0003012) | 4.29260661 |
| 32 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 4.26897036 |
| 33 | neuron recognition (GO:0008038) | 4.19190914 |
| 34 | vocalization behavior (GO:0071625) | 4.16331571 |
| 35 | protein localization to synapse (GO:0035418) | 4.15039758 |
| 36 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 4.08785905 |
| 37 | regulation of calcium ion transmembrane transport (GO:1903169) | 4.08785905 |
| 38 | glycogen catabolic process (GO:0005980) | 4.03992078 |
| 39 | auditory behavior (GO:0031223) | 4.03468781 |
| 40 | skeletal muscle tissue regeneration (GO:0043403) | 3.98183048 |
| 41 | regulation of sarcomere organization (GO:0060297) | 3.96291480 |
| 42 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.95878912 |
| 43 | actomyosin structure organization (GO:0031032) | 3.94862745 |
| 44 | myoblast fusion (GO:0007520) | 3.94678931 |
| 45 | negative regulation of protein localization to cell surface (GO:2000009) | 3.93395609 |
| 46 | behavioral response to nicotine (GO:0035095) | 3.92752637 |
| 47 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.91009979 |
| 48 | muscle organ development (GO:0007517) | 3.88666659 |
| 49 | positive regulation of myotube differentiation (GO:0010831) | 3.83888166 |
| 50 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.82257164 |
| 51 | gamma-aminobutyric acid transport (GO:0015812) | 3.80966130 |
| 52 | muscle structure development (GO:0061061) | 3.80489195 |
| 53 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.79603723 |
| 54 | short-term memory (GO:0007614) | 3.79253394 |
| 55 | negative regulation of potassium ion transport (GO:0043267) | 3.78409424 |
| 56 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.75757217 |
| 57 | glucan catabolic process (GO:0009251) | 3.75146285 |
| 58 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.74274520 |
| 59 | transmission of nerve impulse (GO:0019226) | 3.72980980 |
| 60 | cardiac muscle contraction (GO:0060048) | 3.71315606 |
| 61 | dendritic spine morphogenesis (GO:0060997) | 3.70713664 |
| 62 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.70463965 |
| 63 | retinal ganglion cell axon guidance (GO:0031290) | 3.66855259 |
| 64 | response to muscle activity (GO:0014850) | 3.60564227 |
| 65 | regulation of synapse structural plasticity (GO:0051823) | 3.60312737 |
| 66 | positive regulation of myoblast differentiation (GO:0045663) | 3.59213557 |
| 67 | cardiac myofibril assembly (GO:0055003) | 3.58793752 |
| 68 | synapse assembly (GO:0007416) | 3.57198889 |
| 69 | neuromuscular synaptic transmission (GO:0007274) | 3.49770308 |
| 70 | regulation of membrane repolarization (GO:0060306) | 3.48264849 |
| 71 | establishment of mitochondrion localization (GO:0051654) | 3.48184545 |
| 72 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.45921663 |
| 73 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.45921663 |
| 74 | regulation of coenzyme metabolic process (GO:0051196) | 3.45626286 |
| 75 | regulation of cofactor metabolic process (GO:0051193) | 3.45626286 |
| 76 | striated muscle atrophy (GO:0014891) | 3.45487409 |
| 77 | regulation of striated muscle contraction (GO:0006942) | 3.44772255 |
| 78 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.41113615 |
| 79 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 3.40999007 |
| 80 | muscle cell fate commitment (GO:0042693) | 3.40877710 |
| 81 | cellular polysaccharide catabolic process (GO:0044247) | 3.40746295 |
| 82 | striated muscle cell development (GO:0055002) | 3.39758706 |
| 83 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.39580818 |
| 84 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.37394668 |
| 85 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.37383436 |
| 86 | neuron fate determination (GO:0048664) | 3.37364691 |
| 87 | ATP synthesis coupled proton transport (GO:0015986) | 3.36462012 |
| 88 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.36462012 |
| 89 | skeletal muscle tissue development (GO:0007519) | 3.36312302 |
| 90 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.36233335 |
| 91 | negative regulation of muscle hypertrophy (GO:0014741) | 3.35787496 |
| 92 | protein localization to cilium (GO:0061512) | 3.35156257 |
| 93 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.34307505 |
| 94 | neurofilament cytoskeleton organization (GO:0060052) | 3.33075039 |
| 95 | neuromuscular junction development (GO:0007528) | 3.33060441 |
| 96 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.31601967 |
| 97 | striated muscle adaptation (GO:0014888) | 3.30648361 |
| 98 | neuronal action potential propagation (GO:0019227) | 3.28967608 |
| 99 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.26403721 |
| 100 | myotube differentiation (GO:0014902) | 3.26353946 |
| 101 | regulation of feeding behavior (GO:0060259) | 3.26137405 |
| 102 | synaptic transmission, glutamatergic (GO:0035249) | 3.25658679 |
| 103 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.25229869 |
| 104 | negative regulation of axon guidance (GO:1902668) | 3.24200006 |
| 105 | cell migration in hindbrain (GO:0021535) | 3.23508581 |
| 106 | syncytium formation (GO:0006949) | 3.21484254 |
| 107 | glutamate receptor signaling pathway (GO:0007215) | 3.21456889 |
| 108 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.20920845 |
| 109 | polysaccharide catabolic process (GO:0000272) | 3.18158060 |
| 110 | mechanosensory behavior (GO:0007638) | 3.16120591 |
| 111 | cytidine deamination (GO:0009972) | 3.15729504 |
| 112 | cytidine metabolic process (GO:0046087) | 3.15729504 |
| 113 | cytidine catabolic process (GO:0006216) | 3.15729504 |
| 114 | creatine metabolic process (GO:0006600) | 3.14061479 |
| 115 | response to auditory stimulus (GO:0010996) | 3.10168136 |
| 116 | negative regulation of norepinephrine secretion (GO:0010700) | 3.10132845 |
| 117 | positive regulation of synapse assembly (GO:0051965) | 3.10118103 |
| 118 | synaptic vesicle maturation (GO:0016188) | 3.08392384 |
| 119 | neuronal ion channel clustering (GO:0045161) | 3.08105904 |
| 120 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.07503263 |
| 121 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.06923835 |
| 122 | synaptic vesicle exocytosis (GO:0016079) | 3.05474296 |
| 123 | negative regulation of ion transmembrane transporter activity (GO:0032413) | 3.05179748 |
| 124 | exploration behavior (GO:0035640) | 3.04439746 |
| 125 | limb bud formation (GO:0060174) | 3.04120456 |
| 126 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 3.02595526 |
| 127 | nonmotile primary cilium assembly (GO:0035058) | 3.01393403 |
| 128 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.99628185 |
| 129 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.99187713 |
| 130 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.99116236 |
| 131 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.98023926 |
| 132 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.96033039 |
| 133 | respiratory electron transport chain (GO:0022904) | 2.95779765 |
| 134 | neuron-neuron synaptic transmission (GO:0007270) | 2.95579044 |
| 135 | head development (GO:0060322) | 2.95115287 |
| 136 | muscle atrophy (GO:0014889) | 2.94840078 |
| 137 | epithelial cilium movement (GO:0003351) | 2.94561348 |
| 138 | glutamate secretion (GO:0014047) | 2.93929655 |
| 139 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.93110668 |
| 140 | muscle cell development (GO:0055001) | 2.91760809 |
| 141 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.90420357 |
| 142 | synapse organization (GO:0050808) | 2.88633147 |
| 143 | glycogen biosynthetic process (GO:0005978) | 2.87844510 |
| 144 | glucan biosynthetic process (GO:0009250) | 2.87844510 |
| 145 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.87339161 |
| 146 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.87087563 |
| 147 | locomotory exploration behavior (GO:0035641) | 2.86885383 |
| 148 | electron transport chain (GO:0022900) | 2.86497498 |
| 149 | adult walking behavior (GO:0007628) | 2.85831062 |
| 150 | detection of calcium ion (GO:0005513) | 2.85785493 |
| 151 | dendrite morphogenesis (GO:0048813) | 2.85254785 |
| 152 | cochlea development (GO:0090102) | 2.84773797 |
| 153 | positive regulation of mitochondrial fission (GO:0090141) | 2.82843890 |
| 154 | startle response (GO:0001964) | 2.81558449 |
| 155 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.81337508 |
| 156 | spinal cord development (GO:0021510) | 2.81154259 |
| 157 | carnitine shuttle (GO:0006853) | 2.80997576 |
| 158 | negative regulation of cell size (GO:0045792) | 2.80588645 |
| 159 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.80278203 |
| 160 | regulation of muscle system process (GO:0090257) | 2.76467875 |
| 161 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.75355311 |
| 162 | neurotransmitter secretion (GO:0007269) | 2.74996512 |
| 163 | protein polyglutamylation (GO:0018095) | 2.74994268 |
| 164 | somite development (GO:0061053) | 2.74254789 |
| 165 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.74210601 |
| 166 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.73453756 |
| 167 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.72629143 |
| 168 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.70804818 |
| 169 | mitochondrion transport along microtubule (GO:0047497) | 2.70804818 |
| 170 | tricarboxylic acid cycle (GO:0006099) | 2.69880863 |
| 171 | behavioral response to ethanol (GO:0048149) | 2.68476168 |
| 172 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.68005306 |
| 173 | axon extension (GO:0048675) | 2.67433606 |
| 174 | neuronal action potential (GO:0019228) | 2.65511766 |
| 175 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.64252291 |
| 176 | negative regulation of axonogenesis (GO:0050771) | 2.63721115 |
| 177 | intraciliary transport (GO:0042073) | 2.63710698 |
| 178 | axon ensheathment in central nervous system (GO:0032291) | 2.63132846 |
| 179 | central nervous system myelination (GO:0022010) | 2.63132846 |
| 180 | positive regulation of amino acid transport (GO:0051957) | 2.62077199 |
| 181 | regulation of synaptic vesicle transport (GO:1902803) | 2.60921056 |
| 182 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.59897497 |
| 183 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.59897497 |
| 184 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.59413804 |
| 185 | negative regulation of axon extension (GO:0030517) | 2.57918417 |
| 186 | synaptic transmission, cholinergic (GO:0007271) | 2.56792049 |
| 187 | regulation of axon guidance (GO:1902667) | 2.56377686 |
| 188 | glycosphingolipid biosynthetic process (GO:0006688) | 2.56301039 |
| 189 | negative regulation of microtubule polymerization (GO:0031115) | 2.55252914 |
| 190 | cytoskeleton-dependent intracellular transport (GO:0030705) | 2.55132038 |
| 191 | dendrite development (GO:0016358) | 2.55064637 |
| 192 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) | 2.54362136 |
| 193 | negative regulation of telomere maintenance (GO:0032205) | 2.53980150 |
| 194 | regulation of synapse assembly (GO:0051963) | 2.53261214 |
| 195 | actin-myosin filament sliding (GO:0033275) | 12.7025067 |
| 196 | muscle filament sliding (GO:0030049) | 12.7025067 |
| 197 | skeletal muscle contraction (GO:0003009) | 11.0772013 |
| 198 | actin-mediated cell contraction (GO:0070252) | 10.3495757 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.39833188 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.04791559 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.62723124 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.50423360 |
| 5 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.05624391 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.67666502 |
| 7 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.64631684 |
| 8 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.53735977 |
| 9 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.52632318 |
| 10 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.51284872 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.39483567 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.39483567 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.29717631 |
| 14 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.29458266 |
| 15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.28023197 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.18974766 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.10622291 |
| 18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.08759947 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.02564154 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.98015688 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.97381987 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.91614372 |
| 23 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.86695118 |
| 24 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.85403722 |
| 25 | FUS_26573619_Chip-Seq_HEK293_Human | 1.83858337 |
| 26 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.80980614 |
| 27 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.80333858 |
| 28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.79785701 |
| 29 | EWS_26573619_Chip-Seq_HEK293_Human | 1.79704377 |
| 30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.72645501 |
| 31 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.70711547 |
| 32 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.69747132 |
| 33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.68479423 |
| 34 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.68005379 |
| 35 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.66865152 |
| 36 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.62600733 |
| 37 | VDR_22108803_ChIP-Seq_LS180_Human | 1.60614186 |
| 38 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.55115193 |
| 39 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.53209159 |
| 40 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.51891281 |
| 41 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.49948625 |
| 42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.49162292 |
| 43 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.46261321 |
| 44 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.45765819 |
| 45 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.45416714 |
| 46 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.44718174 |
| 47 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.44472164 |
| 48 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.40955150 |
| 49 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.40726389 |
| 50 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37565051 |
| 51 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.37565051 |
| 52 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.37256561 |
| 53 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.37256561 |
| 54 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.36440862 |
| 55 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.35439159 |
| 56 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.35349964 |
| 57 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.33755187 |
| 58 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.32248471 |
| 59 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.30767257 |
| 60 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.30386826 |
| 61 | P300_19829295_ChIP-Seq_ESCs_Human | 1.28657556 |
| 62 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.28187483 |
| 63 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26883242 |
| 64 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.25330960 |
| 65 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.23631530 |
| 66 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.22528906 |
| 67 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.22473645 |
| 68 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.21553850 |
| 69 | AR_25329375_ChIP-Seq_VCAP_Human | 1.20078546 |
| 70 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.19599451 |
| 71 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.18564765 |
| 72 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17851929 |
| 73 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17758681 |
| 74 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.17291014 |
| 75 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.17263709 |
| 76 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.16546063 |
| 77 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.16463948 |
| 78 | STAT3_23295773_ChIP-Seq_U87_Human | 1.16318870 |
| 79 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.16270601 |
| 80 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.15630211 |
| 81 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.14290508 |
| 82 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.12599532 |
| 83 | TP53_16413492_ChIP-PET_HCT116_Human | 1.12328325 |
| 84 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11503326 |
| 85 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09983996 |
| 86 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.09963072 |
| 87 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.09877050 |
| 88 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.09623669 |
| 89 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.09273979 |
| 90 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.09185622 |
| 91 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.08143014 |
| 92 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.06438609 |
| 93 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06149998 |
| 94 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.06004768 |
| 95 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04527130 |
| 96 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.04092562 |
| 97 | JUN_21703547_ChIP-Seq_K562_Human | 1.03999128 |
| 98 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.03329513 |
| 99 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.02557877 |
| 100 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.02243546 |
| 101 | AR_19668381_ChIP-Seq_PC3_Human | 1.01161431 |
| 102 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.01057496 |
| 103 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99922034 |
| 104 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99896207 |
| 105 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.99223808 |
| 106 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98423193 |
| 107 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.98389305 |
| 108 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.96965709 |
| 109 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96514936 |
| 110 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.95788513 |
| 111 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.95434950 |
| 112 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.95410339 |
| 113 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.95376763 |
| 114 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.95376763 |
| 115 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.95179884 |
| 116 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94888855 |
| 117 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.93813005 |
| 118 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93234953 |
| 119 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.92787114 |
| 120 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92587152 |
| 121 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.92486948 |
| 122 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.92127769 |
| 123 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.92038863 |
| 124 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.91902169 |
| 125 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.91503660 |
| 126 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.90936779 |
| 127 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89104725 |
| 128 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88448689 |
| 129 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.86021342 |
| 130 | TCF4_23295773_ChIP-Seq_U87_Human | 0.85344690 |
| 131 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.84310923 |
| 132 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83984427 |
| 133 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.83278580 |
| 134 | KDM2B_26808549_Chip-Seq_REH_Human | 0.81097648 |
| 135 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.78679119 |
| 136 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.78679119 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 6.49536803 |
| 2 | MP0000749_muscle_degeneration | 5.85963485 |
| 3 | MP0000751_myopathy | 5.68143416 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 4.42437940 |
| 5 | MP0000747_muscle_weakness | 4.07229083 |
| 6 | MP0003646_muscle_fatigue | 3.71196289 |
| 7 | MP0002106_abnormal_muscle_physiology | 3.62991758 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.27515447 |
| 9 | MP0000759_abnormal_skeletal_muscle | 3.23787591 |
| 10 | MP0002102_abnormal_ear_morphology | 3.07599066 |
| 11 | MP0005369_muscle_phenotype | 3.07231709 |
| 12 | MP0002269_muscular_atrophy | 3.04728555 |
| 13 | MP0004087_abnormal_muscle_fiber | 3.03441011 |
| 14 | MP0000750_abnormal_muscle_regeneration | 2.96523091 |
| 15 | MP0004270_analgesia | 2.85584227 |
| 16 | MP0005620_abnormal_muscle_contractility | 2.81623952 |
| 17 | MP0000778_abnormal_nervous_system | 2.57896019 |
| 18 | MP0004233_abnormal_muscle_weight | 2.24415748 |
| 19 | MP0000733_abnormal_muscle_development | 2.23395696 |
| 20 | MP0003950_abnormal_plasma_membrane | 2.13095927 |
| 21 | MP0004084_abnormal_cardiac_muscle | 2.11431152 |
| 22 | MP0001984_abnormal_olfaction | 2.09006441 |
| 23 | MP0002108_abnormal_muscle_morphology | 2.05210679 |
| 24 | MP0004859_abnormal_synaptic_plasticity | 2.03300764 |
| 25 | MP0005330_cardiomyopathy | 2.03122308 |
| 26 | MP0004484_altered_response_of | 2.00788413 |
| 27 | MP0004215_abnormal_myocardial_fiber | 1.99042574 |
| 28 | MP0004130_abnormal_muscle_cell | 1.98151376 |
| 29 | MP0003122_maternal_imprinting | 1.95583005 |
| 30 | MP0003880_abnormal_central_pattern | 1.91585759 |
| 31 | MP0003787_abnormal_imprinting | 1.90865665 |
| 32 | MP0005394_taste/olfaction_phenotype | 1.88392639 |
| 33 | MP0005499_abnormal_olfactory_system | 1.88392639 |
| 34 | MP0002332_abnormal_exercise_endurance | 1.87598063 |
| 35 | MP0004885_abnormal_endolymph | 1.79511388 |
| 36 | MP0008789_abnormal_olfactory_epithelium | 1.74923782 |
| 37 | MP0004133_heterotaxia | 1.68415816 |
| 38 | MP0001485_abnormal_pinna_reflex | 1.62590107 |
| 39 | MP0002653_abnormal_ependyma_morphology | 1.60370270 |
| 40 | MP0002972_abnormal_cardiac_muscle | 1.57085872 |
| 41 | MP0001188_hyperpigmentation | 1.55071239 |
| 42 | MP0006292_abnormal_olfactory_placode | 1.45782568 |
| 43 | MP0004272_abnormal_basement_membrane | 1.44295380 |
| 44 | MP0002882_abnormal_neuron_morphology | 1.43380411 |
| 45 | MP0000049_abnormal_middle_ear | 1.42572889 |
| 46 | MP0002751_abnormal_autonomic_nervous | 1.41671117 |
| 47 | MP0002638_abnormal_pupillary_reflex | 1.41567092 |
| 48 | MP0003635_abnormal_synaptic_transmissio | 1.38747788 |
| 49 | MP0004742_abnormal_vestibular_system | 1.32118593 |
| 50 | MP0000013_abnormal_adipose_tissue | 1.30385038 |
| 51 | MP0005503_abnormal_tendon_morphology | 1.30334683 |
| 52 | MP0000566_synostosis | 1.29604868 |
| 53 | MP0002752_abnormal_somatic_nervous | 1.26818721 |
| 54 | MP0003123_paternal_imprinting | 1.24582169 |
| 55 | MP0006036_abnormal_mitochondrial_physio | 1.24451104 |
| 56 | MP0005551_abnormal_eye_electrophysiolog | 1.24381974 |
| 57 | MP0006276_abnormal_autonomic_nervous | 1.22594501 |
| 58 | MP0004510_myositis | 1.21650222 |
| 59 | MP0003283_abnormal_digestive_organ | 1.21163080 |
| 60 | MP0000631_abnormal_neuroendocrine_gland | 1.21026257 |
| 61 | MP0000026_abnormal_inner_ear | 1.20863028 |
| 62 | MP0005187_abnormal_penis_morphology | 1.19552047 |
| 63 | MP0002734_abnormal_mechanical_nocicepti | 1.18893198 |
| 64 | MP0009745_abnormal_behavioral_response | 1.18814003 |
| 65 | MP0003137_abnormal_impulse_conducting | 1.16058266 |
| 66 | MP0002152_abnormal_brain_morphology | 1.15987661 |
| 67 | MP0003938_abnormal_ear_development | 1.15220572 |
| 68 | MP0003890_abnormal_embryonic-extraembry | 1.13900050 |
| 69 | MP0009780_abnormal_chondrocyte_physiolo | 1.12193571 |
| 70 | MP0008438_abnormal_cutaneous_collagen | 1.11835176 |
| 71 | MP0005275_abnormal_skin_tensile | 1.11432870 |
| 72 | MP0008877_abnormal_DNA_methylation | 1.08360690 |
| 73 | MP0005645_abnormal_hypothalamus_physiol | 1.08356276 |
| 74 | MP0003136_yellow_coat_color | 1.07887840 |
| 75 | MP0008995_early_reproductive_senescence | 1.07366331 |
| 76 | MP0001440_abnormal_grooming_behavior | 1.03100553 |
| 77 | MP0003119_abnormal_digestive_system | 1.02752027 |
| 78 | MP0003861_abnormal_nervous_system | 1.02321532 |
| 79 | MP0002233_abnormal_nose_morphology | 1.02300200 |
| 80 | MP0002928_abnormal_bile_duct | 1.01987635 |
| 81 | MP0002063_abnormal_learning/memory/cond | 0.99942247 |
| 82 | MP0001529_abnormal_vocalization | 0.99695559 |
| 83 | MP0006072_abnormal_retinal_apoptosis | 0.99472182 |
| 84 | MP0001986_abnormal_taste_sensitivity | 0.97773159 |
| 85 | MP0010630_abnormal_cardiac_muscle | 0.96638545 |
| 86 | MP0005646_abnormal_pituitary_gland | 0.95471490 |
| 87 | MP0000569_abnormal_digit_pigmentation | 0.94592073 |
| 88 | MP0009046_muscle_twitch | 0.94073896 |
| 89 | MP0005084_abnormal_gallbladder_morpholo | 0.93195689 |
| 90 | MP0005623_abnormal_meninges_morphology | 0.93029531 |
| 91 | MP0001963_abnormal_hearing_physiology | 0.92511253 |
| 92 | MP0002064_seizures | 0.91824430 |
| 93 | MP0001502_abnormal_circadian_rhythm | 0.90687358 |
| 94 | MP0005253_abnormal_eye_physiology | 0.90454809 |
| 95 | MP0002736_abnormal_nociception_after | 0.89936217 |
| 96 | MP0001968_abnormal_touch/_nociception | 0.89919218 |
| 97 | MP0002971_abnormal_brown_adipose | 0.89313613 |
| 98 | MP0002184_abnormal_innervation | 0.88979253 |
| 99 | MP0001293_anophthalmia | 0.87533620 |
| 100 | MP0004134_abnormal_chest_morphology | 0.87040109 |
| 101 | MP0004085_abnormal_heartbeat | 0.85870007 |
| 102 | MP0003937_abnormal_limbs/digits/tail_de | 0.85420761 |
| 103 | MP0005195_abnormal_posterior_eye | 0.85352661 |
| 104 | MP0001177_atelectasis | 0.82439682 |
| 105 | MP0002069_abnormal_eating/drinking_beha | 0.81954101 |
| 106 | MP0002127_abnormal_cardiovascular_syste | 0.80119991 |
| 107 | MP0005266_abnormal_metabolism | 0.80096291 |
| 108 | MP0010386_abnormal_urinary_bladder | 0.79731858 |
| 109 | MP0002938_white_spotting | 0.79219653 |
| 110 | MP0002572_abnormal_emotion/affect_behav | 0.79096570 |
| 111 | MP0002067_abnormal_sensory_capabilities | 0.78400753 |
| 112 | MP0003121_genomic_imprinting | 0.77281242 |
| 113 | MP0009250_abnormal_appendicular_skeleto | 0.77182971 |
| 114 | MP0002272_abnormal_nervous_system | 0.77054457 |
| 115 | MP0002229_neurodegeneration | 0.76719172 |
| 116 | MP0003755_abnormal_palate_morphology | 0.75368427 |
| 117 | MP0003633_abnormal_nervous_system | 0.75270951 |
| 118 | MP0001299_abnormal_eye_distance/ | 0.75078440 |
| 119 | MP0001286_abnormal_eye_development | 0.73974246 |
| 120 | MP0002282_abnormal_trachea_morphology | 0.73895352 |
| 121 | MP0001501_abnormal_sleep_pattern | 0.73791698 |
| 122 | MP0008569_lethality_at_weaning | 0.73742017 |
| 123 | MP0005385_cardiovascular_system_phenoty | 0.72837834 |
| 124 | MP0001544_abnormal_cardiovascular_syste | 0.72837834 |
| 125 | MP0000534_abnormal_ureter_morphology | 0.72565831 |
| 126 | MP0004142_abnormal_muscle_tone | 0.72180375 |
| 127 | MP0003011_delayed_dark_adaptation | 0.69895035 |
| 128 | MP0000647_abnormal_sebaceous_gland | 0.68476361 |
| 129 | MP0006035_abnormal_mitochondrial_morpho | 0.68109218 |
| 130 | MP0008775_abnormal_heart_ventricle | 0.67937405 |
| 131 | MP0002066_abnormal_motor_capabilities/c | 0.66233389 |
| 132 | MP0002089_abnormal_postnatal_growth/wei | 0.66172905 |
| 133 | MP0002234_abnormal_pharynx_morphology | 0.63112061 |
| 134 | MP0001486_abnormal_startle_reflex | 0.61742501 |
| 135 | MP0002735_abnormal_chemical_nociception | 0.59931939 |
| 136 | MP0003385_abnormal_body_wall | 0.57187305 |
| 137 | MP0002114_abnormal_axial_skeleton | 0.55896188 |
| 138 | MP0004924_abnormal_behavior | 0.55781465 |
| 139 | MP0005386_behavior/neurological_phenoty | 0.55781465 |
| 140 | MP0002822_catalepsy | 0.53558609 |
| 141 | MP0000955_abnormal_spinal_cord | 0.52721974 |
| 142 | MP0001943_abnormal_respiration | 0.52586448 |
| 143 | MP0003879_abnormal_hair_cell | 0.50981897 |
| 144 | MP0003329_amyloid_beta_deposits | 0.49254098 |
| 145 | MP0001970_abnormal_pain_threshold | 0.48672618 |
| 146 | MP0006138_congestive_heart_failure | 0.47938127 |
| 147 | MP0001905_abnormal_dopamine_level | 0.47138684 |
| 148 | MP0003941_abnormal_skin_development | 0.47105207 |
| 149 | MP0004811_abnormal_neuron_physiology | 0.44361202 |
| 150 | MP0005452_abnormal_adipose_tissue | 0.43848987 |
| 151 | MP0000003_abnormal_adipose_tissue | 0.43659869 |
| 152 | MP0002909_abnormal_adrenal_gland | 0.43330360 |
| 153 | MP0002733_abnormal_thermal_nociception | 0.43313516 |
| 154 | MP0000762_abnormal_tongue_morphology | 0.42954129 |
| 155 | MP0005535_abnormal_body_temperature | 0.41859751 |
| 156 | MP0005423_abnormal_somatic_nervous | 0.40922312 |
| 157 | MP0000266_abnormal_heart_morphology | 0.40651267 |
| 158 | MP0003948_abnormal_gas_homeostasis | 0.40177224 |
| 159 | MP0002557_abnormal_social/conspecific_i | 0.38973957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.21777687 |
| 2 | Nemaline bodies (HP:0003798) | 9.17530040 |
| 3 | Muscle fiber inclusion bodies (HP:0100299) | 9.12808881 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 8.22432742 |
| 5 | Round ear (HP:0100830) | 6.59051227 |
| 6 | Exercise-induced myalgia (HP:0003738) | 6.40202397 |
| 7 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.08850363 |
| 8 | Myopathic facies (HP:0002058) | 6.08057006 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 6.05228275 |
| 10 | Ulnar deviation of the wrist (HP:0003049) | 5.92997489 |
| 11 | Exercise-induced muscle cramps (HP:0003710) | 5.60335484 |
| 12 | Calcaneovalgus deformity (HP:0001848) | 5.31283848 |
| 13 | Deformed tarsal bones (HP:0008119) | 4.75021824 |
| 14 | Absent phalangeal crease (HP:0006109) | 4.61291988 |
| 15 | Muscle fiber splitting (HP:0003555) | 4.58400488 |
| 16 | EMG: myopathic abnormalities (HP:0003458) | 4.56781704 |
| 17 | Abnormality of the calf musculature (HP:0001430) | 4.55985006 |
| 18 | Fetal akinesia sequence (HP:0001989) | 4.36329940 |
| 19 | Myokymia (HP:0002411) | 4.07471044 |
| 20 | Slender build (HP:0001533) | 3.94052306 |
| 21 | Difficulty running (HP:0009046) | 3.90306893 |
| 22 | Abnormal finger flexion creases (HP:0006143) | 3.90059302 |
| 23 | Neck muscle weakness (HP:0000467) | 3.87242018 |
| 24 | Hyporeflexia of lower limbs (HP:0002600) | 3.82657734 |
| 25 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.66920615 |
| 26 | Limb dystonia (HP:0002451) | 3.57502235 |
| 27 | Malignant hyperthermia (HP:0002047) | 3.55610731 |
| 28 | Polyphagia (HP:0002591) | 3.46538089 |
| 29 | Trismus (HP:0000211) | 3.46005311 |
| 30 | Frequent falls (HP:0002359) | 3.42382767 |
| 31 | Gait imbalance (HP:0002141) | 3.38908211 |
| 32 | Rimmed vacuoles (HP:0003805) | 3.35823266 |
| 33 | Neoplasm of the heart (HP:0100544) | 3.29904658 |
| 34 | Increased connective tissue (HP:0009025) | 3.28494822 |
| 35 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.26095818 |
| 36 | Myotonia (HP:0002486) | 3.25947858 |
| 37 | True hermaphroditism (HP:0010459) | 3.25019369 |
| 38 | Febrile seizures (HP:0002373) | 3.24530667 |
| 39 | Metatarsus adductus (HP:0001840) | 3.22183176 |
| 40 | Focal seizures (HP:0007359) | 3.21674646 |
| 41 | Drooling (HP:0002307) | 3.21221282 |
| 42 | Increased variability in muscle fiber diameter (HP:0003557) | 3.20480388 |
| 43 | Sudden death (HP:0001699) | 3.13401336 |
| 44 | Cortical dysplasia (HP:0002539) | 3.13202070 |
| 45 | Abnormality of the calcaneus (HP:0008364) | 3.11265578 |
| 46 | Medial flaring of the eyebrow (HP:0010747) | 3.07658440 |
| 47 | Bulbar palsy (HP:0001283) | 3.06701627 |
| 48 | Congenital primary aphakia (HP:0007707) | 2.99785105 |
| 49 | Pancreatic fibrosis (HP:0100732) | 2.96873899 |
| 50 | Abnormality of the corticospinal tract (HP:0002492) | 2.96712702 |
| 51 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.95206050 |
| 52 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.95206050 |
| 53 | Muscle stiffness (HP:0003552) | 2.94002905 |
| 54 | Excessive salivation (HP:0003781) | 2.92021608 |
| 55 | Progressive cerebellar ataxia (HP:0002073) | 2.88533384 |
| 56 | Shoulder girdle muscle weakness (HP:0003547) | 2.86768166 |
| 57 | Nephrogenic diabetes insipidus (HP:0009806) | 2.86309234 |
| 58 | Nephronophthisis (HP:0000090) | 2.85885629 |
| 59 | Myoglobinuria (HP:0002913) | 2.85811170 |
| 60 | Molar tooth sign on MRI (HP:0002419) | 2.79580116 |
| 61 | Abnormality of midbrain morphology (HP:0002418) | 2.79580116 |
| 62 | Gowers sign (HP:0003391) | 2.77220811 |
| 63 | Difficulty climbing stairs (HP:0003551) | 2.76425523 |
| 64 | Spinal rigidity (HP:0003306) | 2.74165434 |
| 65 | Genital tract atresia (HP:0001827) | 2.72905355 |
| 66 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.71140217 |
| 67 | Vaginal atresia (HP:0000148) | 2.69743719 |
| 68 | EMG: neuropathic changes (HP:0003445) | 2.69674762 |
| 69 | Failure to thrive in infancy (HP:0001531) | 2.68012678 |
| 70 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.66719051 |
| 71 | Subaortic stenosis (HP:0001682) | 2.65414525 |
| 72 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.65414525 |
| 73 | Pancreatic cysts (HP:0001737) | 2.65268997 |
| 74 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.64598543 |
| 75 | Generalized muscle weakness (HP:0003324) | 2.63881637 |
| 76 | Abnormality of the neuromuscular junction (HP:0003398) | 2.62691885 |
| 77 | Fatigable weakness (HP:0003473) | 2.62691885 |
| 78 | Pelvic girdle muscle weakness (HP:0003749) | 2.60305273 |
| 79 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.57370879 |
| 80 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.57370879 |
| 81 | Amblyopia (HP:0000646) | 2.55975282 |
| 82 | Weak cry (HP:0001612) | 2.55190552 |
| 83 | Intestinal atresia (HP:0011100) | 2.53739359 |
| 84 | Abnormality of the labia minora (HP:0012880) | 2.51502497 |
| 85 | Sleep apnea (HP:0010535) | 2.49282104 |
| 86 | Urinary urgency (HP:0000012) | 2.48713503 |
| 87 | Lissencephaly (HP:0001339) | 2.46421214 |
| 88 | Hip contracture (HP:0003273) | 2.45918191 |
| 89 | Poor suck (HP:0002033) | 2.45326339 |
| 90 | Specific learning disability (HP:0001328) | 2.45135808 |
| 91 | Dialeptic seizures (HP:0011146) | 2.44492114 |
| 92 | Popliteal pterygium (HP:0009756) | 2.42532002 |
| 93 | Amniotic constriction ring (HP:0009775) | 2.41754091 |
| 94 | Abnormality of placental membranes (HP:0011409) | 2.41754091 |
| 95 | Type 2 muscle fiber atrophy (HP:0003554) | 2.38639419 |
| 96 | Generalized tonic-clonic seizures (HP:0002069) | 2.38294595 |
| 97 | Rhabdomyolysis (HP:0003201) | 2.35278053 |
| 98 | Abnormal eating behavior (HP:0100738) | 2.34184524 |
| 99 | Epileptic encephalopathy (HP:0200134) | 2.34140603 |
| 100 | Retinal dysplasia (HP:0007973) | 2.33815672 |
| 101 | Amyotrophic lateral sclerosis (HP:0007354) | 2.32995341 |
| 102 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 2.32605337 |
| 103 | Ulnar deviation of finger (HP:0009465) | 2.29945263 |
| 104 | Hypoplasia of the brainstem (HP:0002365) | 2.28712967 |
| 105 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.28712967 |
| 106 | Abnormality of the renal medulla (HP:0100957) | 2.27048896 |
| 107 | Agitation (HP:0000713) | 2.24348147 |
| 108 | Hyperventilation (HP:0002883) | 2.23760774 |
| 109 | Ulnar claw (HP:0001178) | 2.22819263 |
| 110 | Muscle fiber atrophy (HP:0100295) | 2.21151279 |
| 111 | Pachygyria (HP:0001302) | 2.19763647 |
| 112 | Broad-based gait (HP:0002136) | 2.18064996 |
| 113 | Absence seizures (HP:0002121) | 2.14618070 |
| 114 | Poor coordination (HP:0002370) | 2.12644025 |
| 115 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.11263308 |
| 116 | Asymmetric septal hypertrophy (HP:0001670) | 2.08593133 |
| 117 | Rib fusion (HP:0000902) | 2.08194348 |
| 118 | Sclerocornea (HP:0000647) | 2.07548762 |
| 119 | Spastic tetraplegia (HP:0002510) | 2.06379173 |
| 120 | Abnormality of the lower motor neuron (HP:0002366) | 2.05823721 |
| 121 | Hemiparesis (HP:0001269) | 2.05190472 |
| 122 | Anencephaly (HP:0002323) | 2.04603451 |
| 123 | Scapular winging (HP:0003691) | 2.03841418 |
| 124 | Spastic gait (HP:0002064) | 2.03696381 |
| 125 | Areflexia of lower limbs (HP:0002522) | 2.03058121 |
| 126 | Gastrointestinal atresia (HP:0002589) | 2.02422235 |
| 127 | Proximal amyotrophy (HP:0007126) | 2.02145175 |
| 128 | Genetic anticipation (HP:0003743) | 2.00676481 |
| 129 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.00669528 |
| 130 | Epileptiform EEG discharges (HP:0011182) | 2.00076387 |
| 131 | Distal arthrogryposis (HP:0005684) | 10.7274111 |
| 132 | Optic nerve hypoplasia (HP:0000609) | 1.99846544 |
| 133 | Waddling gait (HP:0002515) | 1.98941761 |
| 134 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.98628017 |
| 135 | Chronic hepatic failure (HP:0100626) | 1.97845946 |
| 136 | Inability to walk (HP:0002540) | 1.97527875 |
| 137 | Postaxial hand polydactyly (HP:0001162) | 1.97206360 |
| 138 | Septo-optic dysplasia (HP:0100842) | 1.96969443 |
| 139 | Hypsarrhythmia (HP:0002521) | 1.96923036 |
| 140 | Anophthalmia (HP:0000528) | 1.96693593 |
| 141 | Aplasia of the musculature (HP:0100854) | 1.96214004 |
| 142 | Limb-girdle muscle weakness (HP:0003325) | 1.96195939 |
| 143 | Muscular dystrophy (HP:0003560) | 1.93306996 |
| 144 | Progressive inability to walk (HP:0002505) | 1.92876194 |
| 145 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.91381693 |
| 146 | EEG with generalized epileptiform discharges (HP:0011198) | 1.91359087 |
| 147 | Narrow forehead (HP:0000341) | 1.91162846 |
| 148 | Hypoplastic ischia (HP:0003175) | 1.89820754 |
| 149 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.88878701 |
| 150 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.88878701 |
| 151 | Cystic liver disease (HP:0006706) | 1.88397335 |
| 152 | Type II lissencephaly (HP:0007260) | 1.88220892 |
| 153 | Breech presentation (HP:0001623) | 1.85055924 |
| 154 | Exotropia (HP:0000577) | 1.84267608 |
| 155 | Nonprogressive disorder (HP:0003680) | 1.84022689 |
| 156 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.83807016 |
| 157 | Occipital encephalocele (HP:0002085) | 1.81487837 |
| 158 | Esotropia (HP:0000565) | 1.80523746 |
| 159 | Distal lower limb amyotrophy (HP:0008944) | 1.80231942 |
| 160 | Broad foot (HP:0001769) | 1.80009548 |
| 161 | Akinesia (HP:0002304) | 1.78337733 |
| 162 | Split foot (HP:0001839) | 1.78287920 |
| 163 | Limb-girdle muscle atrophy (HP:0003797) | 1.77417050 |
| 164 | Facial diplegia (HP:0001349) | 1.76910593 |
| 165 | Focal motor seizures (HP:0011153) | 1.76445385 |
| 166 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.76240929 |
| 167 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.75964898 |
| 168 | Adducted thumb (HP:0001181) | 1.75309179 |
| 169 | Abnormal ciliary motility (HP:0012262) | 1.75089854 |
| 170 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.74763049 |
| 171 | Hepatoblastoma (HP:0002884) | 1.74058964 |
| 172 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.73244033 |
| 173 | Action tremor (HP:0002345) | 1.71533281 |
| 174 | Acute necrotizing encephalopathy (HP:0006965) | 1.68922924 |
| 175 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.68767436 |
| 176 | Hypothermia (HP:0002045) | 1.68011984 |
| 177 | Status epilepticus (HP:0002133) | 1.67399766 |
| 178 | Growth hormone deficiency (HP:0000824) | 1.66650026 |
| 179 | Abnormality of salivation (HP:0100755) | 1.66392974 |
| 180 | Distal lower limb muscle weakness (HP:0009053) | 1.66373567 |
| 181 | Limited hip movement (HP:0008800) | 1.64842800 |
| 182 | Abnormality of the ischium (HP:0003174) | 1.63105588 |
| 183 | Webbed neck (HP:0000465) | 1.59106439 |
| 184 | Progressive muscle weakness (HP:0003323) | 1.58218999 |
| 185 | Long clavicles (HP:0000890) | 1.52233859 |
| 186 | Tarsal synostosis (HP:0008368) | 1.50495359 |
| 187 | Hyperkalemia (HP:0002153) | 1.49950475 |
| 188 | Rocker bottom foot (HP:0001838) | 1.48226207 |
| 189 | Atonic seizures (HP:0010819) | 1.47022302 |
| 190 | Lower limb amyotrophy (HP:0007210) | 1.46966639 |
| 191 | Achilles tendon contracture (HP:0001771) | 1.44894116 |
| 192 | Easy fatigability (HP:0003388) | 1.44678956 |
| 193 | Congenital hip dislocation (HP:0001374) | 1.40653758 |
| 194 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.38777766 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 9.44991445 |
| 2 | PIK3CG | 4.79234996 |
| 3 | TTN | 3.89476114 |
| 4 | PHKG2 | 3.68136234 |
| 5 | PHKG1 | 3.68136234 |
| 6 | BCR | 3.39762590 |
| 7 | NME1 | 3.37980578 |
| 8 | MUSK | 2.91062047 |
| 9 | WNK3 | 2.55465372 |
| 10 | TRIM28 | 2.39988755 |
| 11 | DYRK2 | 2.20573529 |
| 12 | MAP4K2 | 2.04832319 |
| 13 | UHMK1 | 2.03648220 |
| 14 | DYRK3 | 1.94023133 |
| 15 | MAP2K4 | 1.92840408 |
| 16 | ERBB3 | 1.82472573 |
| 17 | MAPK15 | 1.72748807 |
| 18 | MAP3K12 | 1.72189927 |
| 19 | NTRK3 | 1.67794503 |
| 20 | PDK3 | 1.65683240 |
| 21 | PDK4 | 1.65683240 |
| 22 | CASK | 1.63880126 |
| 23 | EPHA3 | 1.59029332 |
| 24 | NEK1 | 1.56649368 |
| 25 | TNIK | 1.55702010 |
| 26 | MAPK12 | 1.53331895 |
| 27 | EPHA4 | 1.42654343 |
| 28 | MAP3K4 | 1.39638701 |
| 29 | DYRK1B | 1.35854526 |
| 30 | PNCK | 1.34627241 |
| 31 | CSNK1G3 | 1.27218124 |
| 32 | MOS | 1.25974475 |
| 33 | DMPK | 1.23977512 |
| 34 | PINK1 | 1.23292371 |
| 35 | PIK3CA | 1.21539251 |
| 36 | MAP3K9 | 1.19496933 |
| 37 | DYRK1A | 1.18354477 |
| 38 | SIK3 | 1.17809054 |
| 39 | CSNK1A1L | 1.16612102 |
| 40 | TRIB3 | 1.13367212 |
| 41 | SIK1 | 1.12152791 |
| 42 | MAP3K7 | 1.11793528 |
| 43 | ADRBK2 | 1.10070744 |
| 44 | MARK1 | 1.07970616 |
| 45 | GRK7 | 1.06403384 |
| 46 | PLK2 | 1.06170338 |
| 47 | MAP2K3 | 0.99310208 |
| 48 | CSNK1G1 | 0.97622827 |
| 49 | PTK2B | 0.96347881 |
| 50 | EPHB2 | 0.96307791 |
| 51 | PDK2 | 0.93183392 |
| 52 | GRK5 | 0.92870220 |
| 53 | SGK223 | 0.92118807 |
| 54 | SGK494 | 0.92118807 |
| 55 | CCNB1 | 0.87162660 |
| 56 | INSRR | 0.84431516 |
| 57 | CAMK2A | 0.84387288 |
| 58 | RPS6KA4 | 0.84313347 |
| 59 | CAMK2G | 0.83229635 |
| 60 | VRK1 | 0.82561713 |
| 61 | BCKDK | 0.81880720 |
| 62 | WEE1 | 0.81836434 |
| 63 | MAP3K6 | 0.80488092 |
| 64 | MAP2K6 | 0.79598303 |
| 65 | PRKCE | 0.79444312 |
| 66 | MAP2K7 | 0.78850682 |
| 67 | ROCK2 | 0.74544880 |
| 68 | DAPK2 | 0.72679516 |
| 69 | SRPK1 | 0.71431239 |
| 70 | CAMKK2 | 0.69170752 |
| 71 | BMPR1B | 0.68738645 |
| 72 | PAK6 | 0.66168429 |
| 73 | MINK1 | 0.66126653 |
| 74 | MAPKAPK3 | 0.65587957 |
| 75 | WNK4 | 0.64746758 |
| 76 | TSSK6 | 0.64184915 |
| 77 | FRK | 0.64159098 |
| 78 | ILK | 0.64025145 |
| 79 | KSR1 | 0.63938733 |
| 80 | TYRO3 | 0.61791566 |
| 81 | STK39 | 0.60425189 |
| 82 | KSR2 | 0.60178225 |
| 83 | AKT2 | 0.60054971 |
| 84 | MAP2K1 | 0.59352112 |
| 85 | SGK2 | 0.58741467 |
| 86 | ADRBK1 | 0.58035882 |
| 87 | CAMK4 | 0.57119320 |
| 88 | PKN2 | 0.56427091 |
| 89 | MKNK2 | 0.56096206 |
| 90 | LATS2 | 0.55907427 |
| 91 | GRK1 | 0.55492254 |
| 92 | ROCK1 | 0.55179097 |
| 93 | FGR | 0.52871939 |
| 94 | CDK19 | 0.52731623 |
| 95 | PLK3 | 0.52596654 |
| 96 | FGFR2 | 0.52433847 |
| 97 | CAMKK1 | 0.51857326 |
| 98 | MAPKAPK5 | 0.51655425 |
| 99 | MAPK13 | 0.50825926 |
| 100 | MKNK1 | 0.50592376 |
| 101 | CDK5 | 0.49774452 |
| 102 | PRKCZ | 0.48989440 |
| 103 | PRKG1 | 0.48945494 |
| 104 | TLK1 | 0.47429548 |
| 105 | MYLK | 0.47016569 |
| 106 | DAPK1 | 0.46489471 |
| 107 | CDK3 | 0.46298032 |
| 108 | CAMK2D | 0.45746869 |
| 109 | CDK14 | 0.44374112 |
| 110 | CAMK2B | 0.43513914 |
| 111 | FER | 0.42872068 |
| 112 | PRKCG | 0.42322181 |
| 113 | MAPK7 | 0.42008229 |
| 114 | SGK1 | 0.41934057 |
| 115 | CAMK1 | 0.41149030 |
| 116 | ARAF | 0.39346840 |
| 117 | DAPK3 | 0.39184494 |
| 118 | PRKACA | 0.38701426 |
| 119 | PRKACB | 0.38218363 |
| 120 | RPS6KA3 | 0.36886257 |
| 121 | NTRK2 | 0.36597110 |
| 122 | CSNK1A1 | 0.36264497 |
| 123 | TAOK2 | 0.36248520 |
| 124 | STK11 | 0.35559347 |
| 125 | MAP3K5 | 0.34433105 |
| 126 | CDK18 | 0.33949508 |
| 127 | STK24 | 0.33543830 |
| 128 | PRKAA1 | 0.33144383 |
| 129 | RIPK4 | 0.33088451 |
| 130 | PDPK1 | 0.33040260 |
| 131 | CDK15 | 0.32976201 |
| 132 | PKN1 | 0.32769795 |
| 133 | LIMK1 | 0.30025221 |
| 134 | PAK3 | 0.29012021 |
| 135 | CSNK1D | 0.28279483 |
| 136 | PRKD3 | 0.27173813 |
| 137 | MAPK4 | 0.26986642 |
| 138 | GRK6 | 0.26850994 |
| 139 | CDK11A | 0.26195505 |
| 140 | TIE1 | 0.25717240 |
| 141 | ERBB2 | 0.25199407 |
| 142 | MAP3K10 | 0.24680240 |
| 143 | PDK1 | 0.23901766 |
| 144 | MAPK10 | 0.23089651 |
| 145 | PRKAA2 | 0.19662312 |
| 146 | PDGFRA | 0.19029010 |
| 147 | CSNK1E | 0.18824066 |
| 148 | OXSR1 | 0.18249383 |
| 149 | ERBB4 | 0.17432208 |
| 150 | CSNK1G2 | 0.16521492 |
| 151 | MAPK11 | 0.15841159 |
| 152 | NTRK1 | 0.15498552 |
| 153 | SIK2 | 0.15099814 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.10854912 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.21022394 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.14410478 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.00549021 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.76550977 |
| 6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.72802475 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.66443123 |
| 8 | Phototransduction_Homo sapiens_hsa04744 | 2.41672998 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.37221649 |
| 10 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.31517140 |
| 11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.25839134 |
| 12 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.22225255 |
| 13 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.18791439 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.13766850 |
| 15 | Protein export_Homo sapiens_hsa03060 | 2.04701537 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.00222451 |
| 17 | Nicotine addiction_Homo sapiens_hsa05033 | 1.93134232 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.87499451 |
| 19 | Salivary secretion_Homo sapiens_hsa04970 | 1.83710749 |
| 20 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.76681025 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.66480693 |
| 22 | Huntingtons disease_Homo sapiens_hsa05016 | 1.66085659 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 1.65132896 |
| 24 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.60632119 |
| 25 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.59326655 |
| 26 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.55154314 |
| 27 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.54921074 |
| 28 | Long-term depression_Homo sapiens_hsa04730 | 1.53156196 |
| 29 | Long-term potentiation_Homo sapiens_hsa04720 | 1.51334817 |
| 30 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49149044 |
| 31 | Circadian entrainment_Homo sapiens_hsa04713 | 1.46477983 |
| 32 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.45031298 |
| 33 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.44812726 |
| 34 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.43736982 |
| 35 | Tight junction_Homo sapiens_hsa04530 | 1.39463262 |
| 36 | GABAergic synapse_Homo sapiens_hsa04727 | 1.36868030 |
| 37 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.31745715 |
| 38 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.28572847 |
| 39 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.26498590 |
| 40 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.26175212 |
| 41 | Olfactory transduction_Homo sapiens_hsa04740 | 1.22205910 |
| 42 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.19955141 |
| 43 | Morphine addiction_Homo sapiens_hsa05032 | 1.16392575 |
| 44 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.14861903 |
| 45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.14242711 |
| 46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.13952873 |
| 47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.12863707 |
| 48 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.11887118 |
| 49 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.11087403 |
| 50 | Taste transduction_Homo sapiens_hsa04742 | 1.06885069 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.06191936 |
| 52 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.05190267 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02882414 |
| 54 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.99773787 |
| 55 | Gap junction_Homo sapiens_hsa04540 | 0.95176084 |
| 56 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.94840935 |
| 57 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.94642220 |
| 58 | Focal adhesion_Homo sapiens_hsa04510 | 0.93506542 |
| 59 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.91537769 |
| 60 | Alcoholism_Homo sapiens_hsa05034 | 0.90698746 |
| 61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.89243714 |
| 62 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.89213815 |
| 63 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.87291755 |
| 64 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.87264288 |
| 65 | Carbon metabolism_Homo sapiens_hsa01200 | 0.86681594 |
| 66 | Basal transcription factors_Homo sapiens_hsa03022 | 0.86187895 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.85981771 |
| 68 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.85081992 |
| 69 | Circadian rhythm_Homo sapiens_hsa04710 | 0.84351332 |
| 70 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.83911488 |
| 71 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.81399418 |
| 72 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81242952 |
| 73 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.79085800 |
| 74 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.79007539 |
| 75 | Cocaine addiction_Homo sapiens_hsa05030 | 0.78816893 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.77818481 |
| 77 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.77545621 |
| 78 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76804390 |
| 79 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.76479320 |
| 80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.75873609 |
| 81 | Melanogenesis_Homo sapiens_hsa04916 | 0.74223337 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.73373389 |
| 83 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.71649079 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70258402 |
| 85 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.68651370 |
| 86 | Viral myocarditis_Homo sapiens_hsa05416 | 0.65107083 |
| 87 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.64062233 |
| 88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63427118 |
| 89 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.61619134 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61188291 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.61139219 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.60834870 |
| 93 | Bile secretion_Homo sapiens_hsa04976 | 0.59858615 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59234342 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59226091 |
| 96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58139190 |
| 97 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.57608864 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.56744191 |
| 99 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.55598197 |
| 100 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.55003320 |
| 101 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54981102 |
| 102 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.53592416 |
| 103 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53325443 |
| 104 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.53289430 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53219993 |
| 106 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52428991 |
| 107 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.50464729 |
| 108 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50175734 |
| 109 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.49894129 |
| 110 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49790150 |
| 111 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49528113 |
| 112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49014987 |
| 113 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47901248 |
| 114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47424095 |
| 115 | RNA degradation_Homo sapiens_hsa03018 | 0.46774268 |
| 116 | Mineral absorption_Homo sapiens_hsa04978 | 0.46402915 |
| 117 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.45536533 |
| 118 | Axon guidance_Homo sapiens_hsa04360 | 0.45494885 |
| 119 | Glioma_Homo sapiens_hsa05214 | 0.44426603 |
| 120 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.44087789 |
| 121 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.43269683 |
| 122 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.40667026 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40463324 |
| 124 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38305557 |
| 125 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.37749606 |
| 126 | Peroxisome_Homo sapiens_hsa04146 | 0.37090166 |
| 127 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36839575 |
| 128 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.36004172 |
| 129 | Ribosome_Homo sapiens_hsa03010 | 0.34888375 |
| 130 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34483731 |
| 131 | Prion diseases_Homo sapiens_hsa05020 | 0.34472395 |
| 132 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31836521 |
| 133 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.31572442 |
| 134 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.31511430 |
| 135 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.31026231 |
| 136 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.30524187 |
| 137 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30262105 |
| 138 | RNA polymerase_Homo sapiens_hsa03020 | 0.29913474 |
| 139 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29612929 |
| 140 | Platelet activation_Homo sapiens_hsa04611 | 0.29290189 |
| 141 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29277154 |
| 142 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.27699394 |
| 143 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.27569680 |

